The entire course of our lives was suddenly greatly affected by the COVID-19 pandemic. Besides trying to make the efficient vaccines, scientists and doctors all over the world, are still struggling to find the most affective cure for the consequences caused by this disease. As a possible solution, the idea of mesenchymal stem cell therapy emerged. Due to their immunomodulatory, antimicrobial and regenerative properties, they have become a potential drug for patients with more severe consequences of a COVID-19 disease. Also, for some time now, mesenchymal stem cells have been used successfully in the treatment of inflammation, for immunosuppression, tissue regeneration and for the treatment of previously incurable diseases. Since the consequences of a COVID-19 are on the wide spectrum, using mesenchymal stem cell therapy could cure many things at the same time. The therapy for COVID-19 consequences has been already tested on laboratory animals. The results were promising, so the researchers are now begining clinical trials on humans. The first results of the studies are promising, although scientists have encountered a number of obstacles and challenges that will need to be addressed.
|
